ABSORB

Boston Scientific scraps bioresorbable stent program

The decision to can the program follows a succession of setbacks for Abbott’s rival stent that have dented the sector’s hopes of generating big sales.

Nick Paul Taylor Jul 31, 2017 10:18am

Reva gets CE mark for drug-eluting bioresorbable scaffold

Apr 5, 2017 4:30am